针对CCR4受体的新治疗学方法,当前状态和翻译前景:系统性审查

Joana Gorica1, Maria Silvia De Feo1, Ferdinando Corica1

  • 1Department of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.

概括

针对化学因子受体4 (CCR4) 的新型治疗方法对癌症诊断和治疗有希望. 需要进一步的临床翻译来广泛实施这些CCR4向剂.